Table of Content

1. PREFACE
1.1. Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Background of Organ-on-Chip
3.3. Classification of Organ-on-Chip
3.3.1. Single Organ Chip
3.3.2. Disease / Therapeutic Indication Specific Chip
3.3.3. Multi Organ Chip
3.4. Advantages and Limitations of Organ-on-Chip
3.5. Applications of Organ-on-Chip
3.6. Future Perspectives

4. ORGAN-ON-CHIP: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Organ-on-Chip Products and Technologies
4.2.1. Analysis by Type of Offering(s)
4.2.2. Analysis by Type of Model(s)
4.2.3. Analysis by Status of Development
4.2.4. Analysis by Material Used for Construction of Chip or Plate
4.2.5. Analysis by Type of Polymer
4.2.6. Analysis by Compatible Tissue or Organ
4.2.7. Analysis by Application Area(s)
4.2.8. Analysis by Status of Development and Type of Model(s)
4.3. List of Organ on Chip Companies Developing Products and Technology
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Key Players: Analysis by Number of Organ-on-Chip Products and Technologies

5. ORGAN ON CHIP COMPANIES: COMPANY PROFILES
5.1. Chapter Overview
5.2. BEOnChip
5.2.1. Company Overview
5.2.2. Product Portfolio
5.2.3. Recent Developments and Future Outlook
5.3. Dynamic42
5.3.1. Company Overview
5.3.2. Product Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. Emulate
5.4.1. Company Overview
5.4.2. Product Portfolio
5.4.3. Recent Developments and Future Outlook
5.5. Mimetas
5.5.1. Company Overview
5.5.2. Product Portfolio
5.5.3. Recent Developments and Future Outlook
5.6. SynVivo
5.6.1. Company Overview
5.6.2. Product Portfolio
5.6.3. Recent Developments and Future Outlook
5.7 TissUse
5.7.1. Company Overview
5.7.2. Product Portfolio
5.7.3. Recent Developments and Future Outlook
5.8 uFluidix
5.8.1. Company Overview
5.8.2. Product Portfolio
5.8.3. Recent Developments and Future Outlook

6. PATENT ANALYSIS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Organ-on-Chip: Patent Analysis
6.3.1. Analysis by Publication Year
6.3.2. Analysis by Type of Patent and Publication Year
6.3.3. Analysis by Type of Organization
6.3.4. Analysis by Geographical Distribution
6.3.5. Analysis by CPC Symbol
6.3.6. Leading Industry Players: Analysis by Number of Patents
6.3.7. Leading Non-Industry Players: Analysis by Number of Patents
6.4. Organ-on-Chip: Analysis by Patent Valuation
6.5. Leading Patents Based on Number of Citations

7. BRAND POSITIONING MATRIX
7.1. Chapter Overview
7.2 Methodology
7.3. Key Parameters
7.4. Organ-on-Chip Product and Technology Developers: Brand Positioning Matrix
7.4.1. Brand Positioning Matrix: SynVivo
7.4.2. Brand Positioning Matrix: BiomimX
7.4.3. Brand Positioning Matrix: NETRI
7.4.4. Brand Positioning Matrix: Emulate
7.4.5. Brand Positioning Matrix: TissUSe
7.4.6. Brand Positioning Matrix: uFluidix

8. ACADEMIC GRANTS ANALYSIS
8.1 Chapter Overview
8.2. Scope and Methodology
8.3. Organ-on-Chip: Academic Grants Analysis
8.3.1. Analysis by Year of Grant Award
8.3.2. Analysis by Amount Awarded
8.3.3. Analysis by Administering Institute Center
8.3.4. Analysis by Support Period
8.3.5. Analysis by Administering Institute Center and Support Period
8.3.6. Analysis by Administering Institute Center and Amount Awarded (USD Million)
8.3.7. Analysis by Type of Grant Application
8.3.8. Analysis by Purpose of Grant
8.3.9. Analysis by Activity Code
8.3.10. Word Cloud Analysis: Emerging Focus Area
8.3.11. Analysis by Study Section Involved
8.3.12. Popular NIH Departments: Analysis by Number of Grants
8.3.13. Analysis by Type of Recipient Organization
8.3.14. Analysis by Support Period and Amount Awarded
8.3.15. Popular Recipient Organizations: Analysis by Number of Grants
8.3.16. Popular Recipient Organizations: Analysis by Amount Awarded
8.3.17. Analysis by Location of Recipient Organization

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Organ-on-Chip Products and Technologies: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Organ
9.3.5. Analysis by Type of Partner
9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Regional Analysis
9.3.8. Intercontinental and Intracontinental Agreements

10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Organ-on-Chip Products and Technologies: List of Funding and Investments
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Purpose of Funding
10.3.7. Analysis by Associated Organ or System
10.3.8. Analysis by Therapeutic Area
10.3.9. Regional Analysis by Amount Invested
10.3.10. Most Active Players: Analysis by Number of Instances
10.3.11. Most Active Players: Analysis by Amount Raised
10.3.12. Key Investors: Analysis by Number of Funding Instances
10.3.13. Concluding Remarks

11. CASE STUDY: SCAFFOLD-FREE 3D CELL CULTURE SYSTEMS
11.1. Chapter Overview
11.2. Scaffold-free Products: Market Landscape
11.2.1. Analysis by Status of Development
11.2.2. Analysis by Type of System
11.2.3. Analysis by Type of Product
11.2.4. Analysis by Material Used for Fabrication
11.2.5. Analysis by Type of System and Material Used for Fabrication
11.3. Scaffold Free Products: Developer Landscape
11.3.1. Analysis by Year of Establishment
11.3.2. Analysis by Company Size
11.3.3. Analysis by Location of Headquarters

12. ORGAN-ON-CHIP: MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Organ-on-Chip Market, 2022-2035
12.3.1. Global Organ-on-Chip Market, 2022-2035: Distribution by Type of Product
12.3.1.1. Organ-on-Chip Market for Multi-Organ / Organ-based Products, 2022-2035
12.3.1.2. Organ-on-Chip Market for Disease / Therapeutic-based Products, 2022-2035
12.3.2. Global Organ-on-Chip Market, 2022-2035: Distribution by Application Area
12.3.2.1. Organ-on-Chip Market for Drug Discovery and Toxicity Testing, 2022-2035
12.3.2.2. Organ-on-Chip Market for Cancer Research, 2022-2035
12.3.2.3. Organ-on-Chip Market for Tissue Engineering and Regenerative Medicine, 2022-2035
12.3.2.4. Organ-on-Chip Market for Stem Cell Research, 2022-2035
12.3.3. Global Organ-on-Chip Market, 2022-2035: Distribution by Purpose
12.3.3.1. Organ-on-Chip Market for Research Use, 2022-2035
12.3.3.2. Organ-on-Chip Market for Therapy Development, 2022-2035
12.3.4. Global Organ-on-Chip Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. Organ-on-Chip Market in North America, 2022-2035
12.3.4.2. Organ-on-Chip Market in Europe, 2022-2035
12.3.4.3. Organ-on-Chip Market in Asia-Pacific, 2022-2035
12.3.4.4. Organ-on-Chip Market in Rest of the World, 2022-2035
13. CONCLUSION
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cherry Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Pierre Gaudriault, Chief Business Development Officer
14.3. EDmicBio
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Matt Dong-Heon Ha, Chief Executive Officer
14.4. Hesperos
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Michael Shuler, President
14.5. Lena Biosciences
14.5.1. Company Snapshot
14.5.2. Interview Transcript: Jelena Vukasinovic, Chief Executive Officer
14.6. react4life
14.6.1. Company Snapshot
14.6.2. Interview Transcript: Maurizio Aiello, Chief Executive Officer
14.7. Screenin3D
14.7.1. Company Snapshot
14.7.2. Interview Transcript: Michele Zagnoni, Chief Executive Officer
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS